Stress Medication Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: S24F7878AB2EEN
Market Monitor Global

Abstracts

Stress medications are an easy way to combat anxiety and stress. Anxiety drugs are designed specifically to provide near-instant relief from your anxiety symptoms, and although some can still take a few weeks to work, they represent a faster method than therapy and some of the at-home stress reduction techniques.

This report contains market size and forecasts of Stress Medication in Global, including the following market information:

Global Stress Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Stress Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antidepressant Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Stress Medication include Actavis Generics, Sanofi, Dainippon Sumitomo, Janssen Pharmaceuticals, Pfizer, Intra-Cellular Therapies, Inc., Alkermes, Otsuka Pharmaceutical and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stress Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Stress Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Stress Medication Market Segment Percentages, by Type, 2021 (%)

• Antidepressant Drugs
• Atypical Antipsychotics
• Benzodiazepines Medicals

Global Stress Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Stress Medication Market Segment Percentages, by Application, 2021 (%)

• Children
• Adults
• Elderly

Global Stress Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Stress Medication Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Stress Medication revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Stress Medication revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Actavis Generics
• Sanofi
• Dainippon Sumitomo
• Janssen Pharmaceuticals
• Pfizer
• Intra-Cellular Therapies, Inc.
• Alkermes
• Otsuka Pharmaceutical
• Allergan
• Hikma Pharmaceuticals
• Actiza Pharma
• Eli Lilly
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Stress Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Stress Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STRESS MEDICATION OVERALL MARKET SIZE

2.1 Global Stress Medication Market Size: 2021 VS 2028
2.2 Global Stress Medication Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Stress Medication Players in Global Market
3.2 Top Global Stress Medication Companies Ranked by Revenue
3.3 Global Stress Medication Revenue by Companies
3.4 Top 3 and Top 5 Stress Medication Companies in Global Market, by Revenue in 2021
3.5 Global Companies Stress Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stress Medication Players in Global Market
  3.6.1 List of Global Tier 1 Stress Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 Stress Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Stress Medication Market Size Markets, 2021 & 2028
  4.1.2 Antidepressant Drugs
  4.1.3 Atypical Antipsychotics
  4.1.4 Benzodiazepines Medicals
4.2 By Type - Global Stress Medication Revenue & Forecasts
  4.2.1 By Type - Global Stress Medication Revenue, 2017-2022
  4.2.2 By Type - Global Stress Medication Revenue, 2023-2028
  4.2.3 By Type - Global Stress Medication Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Stress Medication Market Size, 2021 & 2028
  5.1.2 Children
  5.1.3 Adults
  5.1.4 Elderly
5.2 By Application - Global Stress Medication Revenue & Forecasts
  5.2.1 By Application - Global Stress Medication Revenue, 2017-2022
  5.2.2 By Application - Global Stress Medication Revenue, 2023-2028
  5.2.3 By Application - Global Stress Medication Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Stress Medication Market Size, 2021 & 2028
6.2 By Region - Global Stress Medication Revenue & Forecasts
  6.2.1 By Region - Global Stress Medication Revenue, 2017-2022
  6.2.2 By Region - Global Stress Medication Revenue, 2023-2028
  6.2.3 By Region - Global Stress Medication Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Stress Medication Revenue, 2017-2028
  6.3.2 US Stress Medication Market Size, 2017-2028
  6.3.3 Canada Stress Medication Market Size, 2017-2028
  6.3.4 Mexico Stress Medication Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Stress Medication Revenue, 2017-2028
  6.4.2 Germany Stress Medication Market Size, 2017-2028
  6.4.3 France Stress Medication Market Size, 2017-2028
  6.4.4 U.K. Stress Medication Market Size, 2017-2028
  6.4.5 Italy Stress Medication Market Size, 2017-2028
  6.4.6 Russia Stress Medication Market Size, 2017-2028
  6.4.7 Nordic Countries Stress Medication Market Size, 2017-2028
  6.4.8 Benelux Stress Medication Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Stress Medication Revenue, 2017-2028
  6.5.2 China Stress Medication Market Size, 2017-2028
  6.5.3 Japan Stress Medication Market Size, 2017-2028
  6.5.4 South Korea Stress Medication Market Size, 2017-2028
  6.5.5 Southeast Asia Stress Medication Market Size, 2017-2028
  6.5.6 India Stress Medication Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Stress Medication Revenue, 2017-2028
  6.6.2 Brazil Stress Medication Market Size, 2017-2028
  6.6.3 Argentina Stress Medication Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Stress Medication Revenue, 2017-2028
  6.7.2 Turkey Stress Medication Market Size, 2017-2028
  6.7.3 Israel Stress Medication Market Size, 2017-2028
  6.7.4 Saudi Arabia Stress Medication Market Size, 2017-2028
  6.7.5 UAE Stress Medication Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Actavis Generics
  7.1.1 Actavis Generics Corporate Summary
  7.1.2 Actavis Generics Business Overview
  7.1.3 Actavis Generics Stress Medication Major Product Offerings
  7.1.4 Actavis Generics Stress Medication Revenue in Global Market (2017-2022)
  7.1.5 Actavis Generics Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Stress Medication Major Product Offerings
  7.2.4 Sanofi Stress Medication Revenue in Global Market (2017-2022)
  7.2.5 Sanofi Key News
7.3 Dainippon Sumitomo
  7.3.1 Dainippon Sumitomo Corporate Summary
  7.3.2 Dainippon Sumitomo Business Overview
  7.3.3 Dainippon Sumitomo Stress Medication Major Product Offerings
  7.3.4 Dainippon Sumitomo Stress Medication Revenue in Global Market (2017-2022)
  7.3.5 Dainippon Sumitomo Key News
7.4 Janssen Pharmaceuticals
  7.4.1 Janssen Pharmaceuticals Corporate Summary
  7.4.2 Janssen Pharmaceuticals Business Overview
  7.4.3 Janssen Pharmaceuticals Stress Medication Major Product Offerings
  7.4.4 Janssen Pharmaceuticals Stress Medication Revenue in Global Market (2017-2022)
  7.4.5 Janssen Pharmaceuticals Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Stress Medication Major Product Offerings
  7.5.4 Pfizer Stress Medication Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Intra-Cellular Therapies, Inc.
  7.6.1 Intra-Cellular Therapies, Inc. Corporate Summary
  7.6.2 Intra-Cellular Therapies, Inc. Business Overview
  7.6.3 Intra-Cellular Therapies, Inc. Stress Medication Major Product Offerings
  7.6.4 Intra-Cellular Therapies, Inc. Stress Medication Revenue in Global Market (2017-2022)
  7.6.5 Intra-Cellular Therapies, Inc. Key News
7.7 Alkermes
  7.7.1 Alkermes Corporate Summary
  7.7.2 Alkermes Business Overview
  7.7.3 Alkermes Stress Medication Major Product Offerings
  7.7.4 Alkermes Stress Medication Revenue in Global Market (2017-2022)
  7.7.5 Alkermes Key News
7.8 Otsuka Pharmaceutical
  7.8.1 Otsuka Pharmaceutical Corporate Summary
  7.8.2 Otsuka Pharmaceutical Business Overview
  7.8.3 Otsuka Pharmaceutical Stress Medication Major Product Offerings
  7.8.4 Otsuka Pharmaceutical Stress Medication Revenue in Global Market (2017-2022)
  7.8.5 Otsuka Pharmaceutical Key News
7.9 Allergan
  7.9.1 Allergan Corporate Summary
  7.9.2 Allergan Business Overview
  7.9.3 Allergan Stress Medication Major Product Offerings
  7.9.4 Allergan Stress Medication Revenue in Global Market (2017-2022)
  7.9.5 Allergan Key News
7.10 Hikma Pharmaceuticals
  7.10.1 Hikma Pharmaceuticals Corporate Summary
  7.10.2 Hikma Pharmaceuticals Business Overview
  7.10.3 Hikma Pharmaceuticals Stress Medication Major Product Offerings
  7.10.4 Hikma Pharmaceuticals Stress Medication Revenue in Global Market (2017-2022)
  7.10.5 Hikma Pharmaceuticals Key News
7.11 Actiza Pharma
  7.11.1 Actiza Pharma Corporate Summary
  7.11.2 Actiza Pharma Business Overview
  7.11.3 Actiza Pharma Stress Medication Major Product Offerings
  7.11.4 Actiza Pharma Stress Medication Revenue in Global Market (2017-2022)
  7.11.5 Actiza Pharma Key News
7.12 Eli Lilly
  7.12.1 Eli Lilly Corporate Summary
  7.12.2 Eli Lilly Business Overview
  7.12.3 Eli Lilly Stress Medication Major Product Offerings
  7.12.4 Eli Lilly Stress Medication Revenue in Global Market (2017-2022)
  7.12.5 Eli Lilly Key News
7.13 AstraZeneca
  7.13.1 AstraZeneca Corporate Summary
  7.13.2 AstraZeneca Business Overview
  7.13.3 AstraZeneca Stress Medication Major Product Offerings
  7.13.4 AstraZeneca Stress Medication Revenue in Global Market (2017-2022)
  7.13.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Stress Medication Market Opportunities & Trends in Global Market
Table 2. Stress Medication Market Drivers in Global Market
Table 3. Stress Medication Market Restraints in Global Market
Table 4. Key Players of Stress Medication in Global Market
Table 5. Top Stress Medication Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Stress Medication Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Stress Medication Revenue Share by Companies, 2017-2022
Table 8. Global Companies Stress Medication Product Type
Table 9. List of Global Tier 1 Stress Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stress Medication Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Stress Medication Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Stress Medication Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Stress Medication Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Stress Medication Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Stress Medication Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Stress Medication Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Stress Medication Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Stress Medication Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Stress Medication Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Stress Medication Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Stress Medication Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Stress Medication Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Stress Medication Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Stress Medication Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Stress Medication Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Stress Medication Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Stress Medication Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Stress Medication Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Stress Medication Revenue, (US$, Mn), 2023-2028
Table 30. Actavis Generics Corporate Summary
Table 31. Actavis Generics Stress Medication Product Offerings
Table 32. Actavis Generics Stress Medication Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Stress Medication Product Offerings
Table 35. Sanofi Stress Medication Revenue (US$, Mn), (2017-2022)
Table 36. Dainippon Sumitomo Corporate Summary
Table 37. Dainippon Sumitomo Stress Medication Product Offerings
Table 38. Dainippon Sumitomo Stress Medication Revenue (US$, Mn), (2017-2022)
Table 39. Janssen Pharmaceuticals Corporate Summary
Table 40. Janssen Pharmaceuticals Stress Medication Product Offerings
Table 41. Janssen Pharmaceuticals Stress Medication Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Stress Medication Product Offerings
Table 44. Pfizer Stress Medication Revenue (US$, Mn), (2017-2022)
Table 45. Intra-Cellular Therapies, Inc. Corporate Summary
Table 46. Intra-Cellular Therapies, Inc. Stress Medication Product Offerings
Table 47. Intra-Cellular Therapies, Inc. Stress Medication Revenue (US$, Mn), (2017-2022)
Table 48. Alkermes Corporate Summary
Table 49. Alkermes Stress Medication Product Offerings
Table 50. Alkermes Stress Medication Revenue (US$, Mn), (2017-2022)
Table 51. Otsuka Pharmaceutical Corporate Summary
Table 52. Otsuka Pharmaceutical Stress Medication Product Offerings
Table 53. Otsuka Pharmaceutical Stress Medication Revenue (US$, Mn), (2017-2022)
Table 54. Allergan Corporate Summary
Table 55. Allergan Stress Medication Product Offerings
Table 56. Allergan Stress Medication Revenue (US$, Mn), (2017-2022)
Table 57. Hikma Pharmaceuticals Corporate Summary
Table 58. Hikma Pharmaceuticals Stress Medication Product Offerings
Table 59. Hikma Pharmaceuticals Stress Medication Revenue (US$, Mn), (2017-2022)
Table 60. Actiza Pharma Corporate Summary
Table 61. Actiza Pharma Stress Medication Product Offerings
Table 62. Actiza Pharma Stress Medication Revenue (US$, Mn), (2017-2022)
Table 63. Eli Lilly Corporate Summary
Table 64. Eli Lilly Stress Medication Product Offerings
Table 65. Eli Lilly Stress Medication Revenue (US$, Mn), (2017-2022)
Table 66. AstraZeneca Corporate Summary
Table 67. AstraZeneca Stress Medication Product Offerings
Table 68. AstraZeneca Stress Medication Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Stress Medication Segment by Type in 2021
Figure 2. Stress Medication Segment by Application in 2021
Figure 3. Global Stress Medication Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Stress Medication Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Stress Medication Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stress Medication Revenue in 2021
Figure 8. By Type - Global Stress Medication Revenue Market Share, 2017-2028
Figure 9. By Application - Global Stress Medication Revenue Market Share, 2017-2028
Figure 10. By Region - Global Stress Medication Revenue Market Share, 2017-2028
Figure 11. By Country - North America Stress Medication Revenue Market Share, 2017-2028
Figure 12. US Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Stress Medication Revenue Market Share, 2017-2028
Figure 16. Germany Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 17. France Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Stress Medication Revenue Market Share, 2017-2028
Figure 24. China Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 28. India Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Stress Medication Revenue Market Share, 2017-2028
Figure 30. Brazil Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Stress Medication Revenue Market Share, 2017-2028
Figure 33. Turkey Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Stress Medication Revenue, (US$, Mn), 2017-2028
Figure 37. Actavis Generics Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Dainippon Sumitomo Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Janssen Pharmaceuticals Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Intra-Cellular Therapies, Inc. Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alkermes Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Otsuka Pharmaceutical Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Allergan Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Hikma Pharmaceuticals Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Actiza Pharma Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Eli Lilly Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. AstraZeneca Stress Medication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)